Cite

HARVARD Citation

    Tamura, K. et al. (2016). Phase I study of palbociclib, a cyclin‐dependent kinase 4/6 inhibitor, in Japanese patients. Cancer science. 107 (6), pp. 755-763. [Online]. 
  
Back to record